These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16641890)

  • 41. Involvement of hemoglobins in the pathophysiology of Alzheimer's disease.
    Altinoz MA; Guloksuz S; Schmidt-Kastner R; Kenis G; Ince B; Rutten BPF
    Exp Gerontol; 2019 Oct; 126():110680. PubMed ID: 31382012
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Exploring the formation of Alzheimer's disease senile plaques in silico.
    Edelstein-keshet L; Spiros A
    J Theor Biol; 2002 Jun; 216(3):301-26. PubMed ID: 12183120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ammonia and Alzheimer's disease.
    Seiler N
    Neurochem Int; 2002; 41(2-3):189-207. PubMed ID: 12020619
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Possible use of adaptation to hypoxia in Alzheimer's disease: a hypothesis.
    Malyshev IY; Wiegant FA; Mashina SY; Torshin VI; Goryacheva AV; Khomenko IP; Kruglov SV; Pokidyshev DA; Popkova EV; Pshennikova MG; Vlasova MA; Zelenina OM; Manukhina EB
    Med Sci Monit; 2005 Aug; 11(8):HY31-8. PubMed ID: 16049387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Potential Role of Chemokines in Alzheimer's Disease Pathogenesis.
    Azizi G; Khannazer N; Mirshafiey A
    Am J Alzheimers Dis Other Demen; 2014 Aug; 29(5):415-25. PubMed ID: 24408754
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dual role of nitric oxide in Alzheimer's disease.
    Azargoonjahromi A
    Nitric Oxide; 2023 May; 134-135():23-37. PubMed ID: 37019299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alzheimer's Disease - Future Therapy Based on Dendrimers.
    Aliev G; Ashraf GM; Tarasov VV; Chubarev VN; Leszek J; Gasiorowski K; Makhmutovа A; Baeesa SS; Avila-Rodriguez M; Ustyugov AA; Bachurin SO
    Curr Neuropharmacol; 2019; 17(3):288-294. PubMed ID: 30227819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type.
    Law A; Gauthier S; Quirion R
    Brain Res Brain Res Rev; 2001 Mar; 35(1):73-96. PubMed ID: 11245887
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Complement in the brain.
    Veerhuis R; Nielsen HM; Tenner AJ
    Mol Immunol; 2011 Aug; 48(14):1592-603. PubMed ID: 21546088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The role of extracellular α-synuclein in molecular mechanisms of cell death].
    Kaźmierczak A; Adamczyk A; Benigna-Strosznajder J
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1047-57. PubMed ID: 24184956
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The immune system on the TRAIL of Alzheimer's disease.
    Burgaletto C; Munafò A; Di Benedetto G; De Francisci C; Caraci F; Di Mauro R; Bucolo C; Bernardini R; Cantarella G
    J Neuroinflammation; 2020 Oct; 17(1):298. PubMed ID: 33050925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Vascular factors in the pathogenesis of Alzheimer's disease].
    Lange-Asschenfeldt C
    Nervenarzt; 2013 Jun; 84(6):732-7. PubMed ID: 23695007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular approaches to the treatment, prophylaxis, and diagnosis of Alzheimer's disease: endoplasmic reticulum stress and immunological stress in pathogenesis of Alzheimer's disease.
    Hosoi T; Ozawa K
    J Pharmacol Sci; 2012; 118(3):319-24. PubMed ID: 22382658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Free radical damage, iron, and Alzheimer's disease.
    Smith MA; Perry G
    J Neurol Sci; 1995 Dec; 134 Suppl():92-4. PubMed ID: 8847550
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improved cognitive and memory abilities in a patient with Alzheimer's disease treated with activated immune cells: Immune cell therapy may benefit more AD patients.
    Laumbacher B; Fellerhoff-Loesch B; Wank R
    Med Hypotheses; 2017 Feb; 99():19-22. PubMed ID: 28110690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miRNAs in Alzheimer Disease - A Therapeutic Perspective.
    Gupta P; Bhattacharjee S; Sharma AR; Sharma G; Lee SS; Chakraborty C
    Curr Alzheimer Res; 2017; 14(11):1198-1206. PubMed ID: 28847283
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Getting to NO Alzheimer's Disease: Neuroprotection versus Neurotoxicity Mediated by Nitric Oxide.
    Balez R; Ooi L
    Oxid Med Cell Longev; 2016; 2016():3806157. PubMed ID: 26697132
    [TBL] [Abstract][Full Text] [Related]  

  • 58. NETosis in Alzheimer's Disease.
    Pietronigro EC; Della Bianca V; Zenaro E; Constantin G
    Front Immunol; 2017; 8():211. PubMed ID: 28303140
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The leukotriene signaling pathway: a druggable target in Alzheimer's disease.
    Michael J; Marschallinger J; Aigner L
    Drug Discov Today; 2019 Feb; 24(2):505-516. PubMed ID: 30240876
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Alzheimer disease and the role of free radicals in the pathogenesis of the disease.
    Moreira PI; Santos MS; Oliveira CR; Shenk JC; Nunomura A; Smith MA; Zhu X; Perry G
    CNS Neurol Disord Drug Targets; 2008 Feb; 7(1):3-10. PubMed ID: 18289026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.